1. Home
  2. LEGN vs PNFP Comparison

LEGN vs PNFP Comparison

Compare LEGN & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • PNFP
  • Stock Information
  • Founded
  • LEGN 2014
  • PNFP 2000
  • Country
  • LEGN United States
  • PNFP United States
  • Employees
  • LEGN N/A
  • PNFP N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • PNFP Major Banks
  • Sector
  • LEGN Health Care
  • PNFP Finance
  • Exchange
  • LEGN Nasdaq
  • PNFP Nasdaq
  • Market Cap
  • LEGN 9.1B
  • PNFP 9.8B
  • IPO Year
  • LEGN 2020
  • PNFP N/A
  • Fundamental
  • Price
  • LEGN $38.19
  • PNFP $123.22
  • Analyst Decision
  • LEGN Strong Buy
  • PNFP Buy
  • Analyst Count
  • LEGN 13
  • PNFP 11
  • Target Price
  • LEGN $81.46
  • PNFP $104.91
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • PNFP 504.0K
  • Earning Date
  • LEGN 11-12-2024
  • PNFP 10-15-2024
  • Dividend Yield
  • LEGN N/A
  • PNFP 0.71%
  • EPS Growth
  • LEGN N/A
  • PNFP N/A
  • EPS
  • LEGN N/A
  • PNFP 5.24
  • Revenue
  • LEGN $520,183,000.00
  • PNFP $1,550,522,000.00
  • Revenue This Year
  • LEGN $110.04
  • PNFP N/A
  • Revenue Next Year
  • LEGN $77.16
  • PNFP $13.32
  • P/E Ratio
  • LEGN N/A
  • PNFP $23.64
  • Revenue Growth
  • LEGN 122.96
  • PNFP N/A
  • 52 Week Low
  • LEGN $38.02
  • PNFP $70.03
  • 52 Week High
  • LEGN $70.13
  • PNFP $129.39
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.40
  • PNFP 70.56
  • Support Level
  • LEGN $38.94
  • PNFP $122.65
  • Resistance Level
  • LEGN $41.87
  • PNFP $129.39
  • Average True Range (ATR)
  • LEGN 2.20
  • PNFP 3.59
  • MACD
  • LEGN -0.30
  • PNFP 1.34
  • Stochastic Oscillator
  • LEGN 1.74
  • PNFP 82.44

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. Pinnacle operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

Share on Social Networks: